Lawmakers Want FDA Chief to Detail Drug Shortage (Corrected)

March 10, 2020, 2:07 PM UTC

U.S. House lawmakers want to know more details about how the FDA intends to handle drug and medical device shortage because of the coronavirus.

  • Lawmakers also called for a briefing from FDA head Stephen Hahn
  • Letter dated Monday signed by Chairman of Energy and Commerce Committee Frank Pallone (D-NJ), Health subcommittee chairwoman Anna Eshoo (D-Calif.) and E&C Ranking Member Greg Walden (R-Ore.)

To contact the reporter on this story:
Jacquie Lee in Washington at jlee2343@bloomberg.net

To contact the editors responsible for this story:
Kasia Klimasinska at kklimasinska@bloomberg.net

Vivek Shankar

© 2020 Bloomberg L.P. All rights reserved. Used with permission.

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.